Neonatal jaundice: Difference between revisions

m (Rossdonaldson1 moved page Neonatal Jaundice to Neonatal jaundice)
No edit summary
Line 2: Line 2:
*Must distinguish between unconjugated and conjugated hyperbili
*Must distinguish between unconjugated and conjugated hyperbili
**Conjugated is always pathologic
**Conjugated is always pathologic
=== Risk Factors ===
*Isoimmune hemolytic disease
*G6PD deficiency
*Asphyxia
*Significant lethargy
*Temperature instability
*Sepsis
*Acidosis


== Work-Up ==
== Work-Up ==
#Tbil/Dbil
*Tbil/Dbil
#CBC (for hemolytic anemia)
*CBC (for hemolytic anemia)
#Coombs or T&S (mom & baby)
*Coombs or T&S (mom & baby)


== DDx ==
== DDx ==
Common
Common
#Physiologic
*Physiologic
#Breast Milk Jaundice
*Breast Milk Jaundice
##Due to substances in milk that inhibit glucuronyl transferase
**Due to substances in milk that inhibit glucuronyl transferase
##May start as early as 3rd day, reaches peak by 3rd week of life
**May start as early as 3rd day, reaches peak by 3rd week of life
##Unlikely to cause kernicterus
**Unlikely to cause kernicterus
#Breast-Feeding Jaundice (starvation jaundice)
*Breast-Feeding Jaundice (starvation jaundice)
##Pt does not receive adequate oral intake
**Pt does not receive adequate oral intake
###Results in reduced bowel movement/bilirubin excretion
***Results in reduced bowel movement/bilirubin excretion
Uncommon
Uncommon
#Direct (conjugated, post- liver obstructive)
*Direct (conjugated, post- liver obstructive)
##congenital biliary atresia
**congenital biliary atresia
##neuroblastoma
**neuroblastoma
##cholesterol cysts
**cholesterol cysts
#Cellular
*Cellular
##[[hepatitis]]
**[[hepatitis]]
##galactosemia
**galactosemia
##[[sepsis]]
**[[sepsis]]
##TORCHS
**TORCHS
##tyrosinemia
**tyrosinemia
##alpha 1 antitrypsis deficiency
**alpha 1 antitrypsis deficiency
#Indirect (unconjugated, pre-liver)
*Indirect (unconjugated, pre-liver)
##[[sepsis]]
**[[sepsis]]
##[[hypotension]]
**[[hypotension]]
##rH/ABO incompatibility
**rH/ABO incompatibility
##G6PD Deficiency
**G6PD Deficiency
##RBC membrane defects
**RBC membrane defects


== Treatment ==
== Treatment ==
Line 48: Line 57:


== Phototherapy Guidelines ==
== Phototherapy Guidelines ==
See [http://bilitool.org/ <font color="#14456e">http://bilitool.org/</font>]
See [http://bilitool.org/ <font color="*14456e">http://bilitool.org/</font>]
{| cellpadding="1" cellspacing="1" width="200" border="1"
{| cellpadding="1" cellspacing="1" width="200" border="1"
|-
|-
Line 97: Line 106:
High Risk: 35-37wk + risk factors
High Risk: 35-37wk + risk factors


== Risk Factors ==
#Isoimmune hemolytic disease
#G6PD deficiency
#Asphyxia
#Significant lethargy
#Temperature instability
#Sepsis
#Acidosis


== Source ==
 
UpToDate, Tintinalli
== References ==


[[Category:Peds]]
[[Category:Peds]]

Revision as of 17:21, 10 May 2015

Background

  • Must distinguish between unconjugated and conjugated hyperbili
    • Conjugated is always pathologic

Risk Factors

  • Isoimmune hemolytic disease
  • G6PD deficiency
  • Asphyxia
  • Significant lethargy
  • Temperature instability
  • Sepsis
  • Acidosis

Work-Up

  • Tbil/Dbil
  • CBC (for hemolytic anemia)
  • Coombs or T&S (mom & baby)

DDx

Common

  • Physiologic
  • Breast Milk Jaundice
    • Due to substances in milk that inhibit glucuronyl transferase
    • May start as early as 3rd day, reaches peak by 3rd week of life
    • Unlikely to cause kernicterus
  • Breast-Feeding Jaundice (starvation jaundice)
    • Pt does not receive adequate oral intake
      • Results in reduced bowel movement/bilirubin excretion

Uncommon

  • Direct (conjugated, post- liver obstructive)
    • congenital biliary atresia
    • neuroblastoma
    • cholesterol cysts
  • Cellular
    • hepatitis
    • galactosemia
    • sepsis
    • TORCHS
    • tyrosinemia
    • alpha 1 antitrypsis deficiency
  • Indirect (unconjugated, pre-liver)

Treatment

  • Breast Milk Jaundice
    • Do not need to routinely d/c breast-feeding
    • Treat w/ phototherapy when necessary
  • Breast-Feeding Jaundice
    • Supplement with expressed breast milk or formula
  • Exchange transfusion
    • Consider if signs of bilirubin encephalopathy
      • Hypertonia, arching, retrocollis, opisthotonos

Phototherapy Guidelines

See http://bilitool.org/

Age Low risk pt cut-off Med risk pt cut-off High risk pt cut-off
Birth 7.0 5.0 4.0
24h 11.5 9.0 8.0
48h 15 14 10
72h 17.5 15 14
96h 20 17.5

14.5

5+day 21 17.5 15
  • Use total bilirubin

Low Risk: >=38wk + no risk factors

Med Risk: (>=38wk + risk factors) or (35-37 wk and no risk factors)

High Risk: 35-37wk + risk factors


References